CAN EXPOSURE-BASED CBT EXTEND IV KETAMINE’S EFFECTS IN OCD? AN OPEN-LABEL TRIAL

European Neuropsychopharmacology, pp. 770-771, 2018.

Cited by: 0|Bibtex|Views1|

Abstract:

Abtract Introduction A single subanesthetic intravenous (IV) dose of ketamine leads to rapid anti-obsessional effects in obsessive-compulsive disorder (OCD) patients with near-constant intrusive obsessions, but these effects usually do not persist. We tested whether a brief course of exposure-based cognitive behavioral therapy (CBT) co...More

Code:

Data:

Your rating :
0

 

Tags
Comments